CCM
JAZZ icon

Coldstream Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Coldstream Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$927K Buy
3,849
+445
+13% +$97.5K 0.01% 507
2026
Q1 		$644K Sell
3,404
-682
-17% -$119K 0.01% 620
2025
Q4 		$695K Sell
4,086
-386
-9% -$59.2K 0.01% 570
2025
Q3 		$589K Buy
4,472
+1,195
+36% +$143K 0.01% 666
2025
Q2 		$348K Sell
3,277
-399
-11% -$43.3K 0.01% 809
2025
Q1 		$456K Buy
3,676
+299
+9% +$39K 0.01% 651
2024
Q4 		$416K Buy
3,377
+1,077
+47% +$127K 0.01% 681
2024
Q3 		$259K Buy
2,300
+165
+8% +$18.1K 0.01% 910
2024
Q2 		$228K Buy
2,135
+299
+16% +$32.9K 0.01% 885
2024
Q1 		$221K Sell
1,836
-8
-0.4% -$980 0.01% 908
2023
Q4 		$227K Buy
+1,844
New +$230K 0.01% 836
2023
Q2 		– Sell
-1,758
Closed -$257K – 848
2023
Q1 		$257K Sell
1,758
-58
-3% -$8.58K 0.01% 676
2022
Q4 		$289K Buy
+1,816
New +$266K 0.01% 612
2022
Q2 		$340K Buy
2,174
+826
+61% +$127K 0.01% 514
2022
Q1 		$210K Buy
+1,348
New +$196K 0.01% 732

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Coldstream Capital Management's JAZZ Position: Q2 2026 in Review

Coldstream Capital Management increased its Jazz Pharmaceuticals (JAZZ) stake by 13% in Q2 2026, buying an estimated $97.5K and bringing the position to 3,849 shares worth $927K. The position accounts for 0.01% of the portfolio, ranked #507.

Coldstream Capital Management first reported a position in JAZZ in Q1 2022 and has held it in 15 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Coldstream Capital Management held 3,849 shares of Jazz Pharmaceuticals worth $927K as of Q2 2026.
  • Coldstream Capital Management bought 445 Jazz Pharmaceuticals shares in Q2 2026, an estimated $97.5K.
  • Jazz Pharmaceuticals made up 0.01% of Coldstream Capital Management's portfolio in Q2 2026, its #507 holding.
  • Coldstream Capital Management first reported a position in Jazz Pharmaceuticals in Q1 2022 and has held it in 15 quarters since.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Coldstream Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.